A detailed history of Jpmorgan Chase & CO transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 326,228 shares of TLRY stock, worth $564,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares
326,228
Previous 428,714 23.91%
Holding current value
$564,374
Previous $1.06 Million 48.87%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$1.62 - $2.85 $166,027 - $292,085
-102,486 Reduced 23.91%
326,228 $541,000
Q1 2024

May 10, 2024

SELL
$1.6 - $2.48 $102,502 - $158,878
-64,064 Reduced 13.0%
428,714 $1.06 Million
Q4 2023

Feb 12, 2024

BUY
$1.66 - $2.41 $139,518 - $202,553
84,047 Added 20.56%
492,778 $1.13 Million
Q3 2023

Nov 14, 2023

SELL
$1.55 - $3.31 $83,095 - $177,449
-53,610 Reduced 11.6%
408,731 $976,000
Q2 2023

Aug 11, 2023

BUY
$1.52 - $2.78 $124,234 - $227,217
81,733 Added 21.47%
462,341 $721,000
Q1 2023

May 18, 2023

BUY
$2.36 - $3.35 $811,960 - $1.15 Million
344,051 Added 941.14%
380,608 $962,000
Q1 2023

May 11, 2023

SELL
$2.36 - $3.35 $694,378 - $985,663
-294,228 Reduced 88.95%
36,557 $92,000
Q4 2022

Feb 13, 2023

BUY
$2.58 - $4.68 $36,380 - $65,992
14,101 Added 4.45%
330,785 $890,000
Q3 2022

Nov 14, 2022

BUY
$2.7 - $4.3 $115,946 - $184,654
42,943 Added 15.69%
316,684 $871,000
Q2 2022

Aug 11, 2022

BUY
$3.11 - $7.48 $21,185 - $50,953
6,812 Added 2.55%
273,741 $854,000
Q1 2022

May 11, 2022

BUY
$4.88 - $8.56 $124,967 - $219,204
25,608 Added 10.61%
266,929 $2.07 Million
Q4 2021

Feb 10, 2022

BUY
$7.03 - $13.03 $1.47 Million - $2.73 Million
209,359 Added 655.02%
241,321 $1.7 Million
Q3 2021

Nov 12, 2021

BUY
$11.11 - $17.84 $355,097 - $570,202
31,962 New
31,962 $361,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $1.06B
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.